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Abstract We report three patients with terminal ileitis and
positive fecal cultures with Yersinia pseudotuberculosis. From
one patient, a virulence plasmid (pYV)-negative Y. pseudotu-
berculosis was isolated, which represents the second finding
of a pYV-negative isolate associated with human disease. All
patients were treated with ciprofloxacin and fully recovered.
Since conventional culture methods for yersiniosis are gradu-
ally replaced with molecular tests not recognizing Y. pseudo-
tuberculosis, we recommend to include a specific culture
medium or to apply a specific polymerase chain reaction
(PCR) assay on fecal samples from patients suspected of
terminal ileitis.
Introduction
The genus Yersinia belongs to the family of Enterobacteriaceae
and is composed of 11 species, of which only Y. pestis, Y.
pseudotuberculosis, and some Y. enterocolitica serotypes are
human pathogens [1–3]. While Y. pestis is known as the caus-
ative agent of the plague and causes no gastrointestinal disease,
Y. enterocolitica and Y. pseudotuberculosis are known as caus-
ative agents of gastrointestinal disease [1–4].
Y. pseudotuberculosis is a zoonotic pathogen transmitted by
the fecal–oral route that has been recovered from various
rodents, rabbits, deer, bats, farm animals, and wild and domes-
tic birds [2, 3, 5, 6]. In 1883, Knapp andMasshoff were the first
to isolate Y. pseudotuberculosis from a mesenteric lymph node
of a patient with a clinical syndrome of acute appendicitis [7].
After an incubation time of 3–7 days, Y. pseudotuberculosis
may cause mucosal ulceration in the terminal ileum and, some-
times, the adjacent colon, lesions in Peyer’s patches, and en-
largement of mesenteric lymph nodes [8, 9]. In severe cases,
septicemia, thrombosis of mesenteric vessels, focal abscesses,
intestinal necrosis, and hemorrhage may occur. Predisposing
host factors for a severe course are diabetes mellitus, liver
cirrhosis, and hemochromatosis [10, 11]. Post-infectious com-
plications such as reactive (poly)arthritis and erythema
nodosum can result from an immunological reaction within
several weeks [2].
Y. pseudotuberculosis is a pleomorphic, facultative anaer-
obic, non-spore-forming, Gram-negative rod that grows at
temperatures ranging from 4 to 43 °C, with the optimal
temperature being between 25 and 28 °C. Y. pseudotubercu-
losis grows on most routine media, including MacConkey,
blood, and chocolate agar, incubated at 35 °C in ambient air,
but may be overgrown by other enteric bacteria in clinical
samples. Therefore, a selective agar, cefsulodin–irgasan–no-
vobiocin (CIN) agar, incubated at 25–28 °C, is used for the
isolation of Y. pseudotuberculosis from fecal samples [12–14].
CIN agar contains D-mannitol and fermentation of this carbo-
hydrate in the presence of neutral red produces characteristic
red colonies. Other bacteria, such as Plesiomonas and
Aeromonas species, also grow on CIN agar, but these can be
differentiated from Yersinia species by their positive oxidase
test. Y. pseudotuberculosis can be serotyped based on O-
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somatic antigen, which is the most distal component of the
lipopolysaccharide membrane. Twenty-one serotypes have
been identified, with O Group I (O:1) accounting for most
human cases and sometimes O:2 or O:3 [2, 15]. The virulence
of Y. pseudotuberculosis is associated with the presence of
multiple virulence markers, including the plasmid of Yersinia
virulence (pYV), the invasion adhesionmolecule (invA) gene,
the attachment invasion locus (ail) gene, and the high patho-
genicity island (HPI) [1–3, 16–19].
We report three patients with terminal ileitis due to Y.
pseudotuberculosis diagnosed by conventional culture.
Case reports
Case 1
A previously healthy 24-year-old female was admitted to a
local hospital with progressive right lower quadrant abdominal
pain, suspected of appendicitis. There was no diarrhea and
temperature was 37.7 °C. On physical examination, there
was pain on percussion and rebound tenderness of the right
lower abdominal quadrant. Laboratory examinations showed a
leukocytosis (total white cell count 12.1×109/l), an elevated
C-reactive protein level (49 mg/l), and no other abnormalities.
A pregnancy test was negative and urine sediment was normal.
A computed tomography (CT) scan showed a normal appen-
dix, significant thickening of the terminal ileum wall over a
length of 7 cm, thickening of the adjacent cecumwall, enlarged
mesenteric lymph nodes, and no free intraperitoneal fluid.
Morbus Crohn was suspected, and prednisone and azathi-
oprine were started. A colonoscopy was performed and re-
vealed a swollen mucous membrane with little ulceration of
the terminal ileum and adjacent cecum. Biopsies were
performed and pathological examination showed no signs of
M. Crohn or idiopathic colitis. To exclude an infectious origin,
a fecal culture was performed. The fecal culture revealed
growth of Y. pseudotuberculosis on CIN medium. Prednisone
and azathioprine were stopped and the patient was treated with
ciprofloxacin 500 mg twice daily for 5 days. At follow up
2 months later, there were no complaints, laboratory exami-
nations were normal, and a magnetic resonance imaging
(MRI) enterography showed no abnormalities.
Case 2
A previously healthy 17-year-old female presented to the emer-
gency department with progressive right lower quadrant ab-
dominal pain since 5 days, suspected of appendicitis. There was
no diarrhea and temperature was 38.3 °C. On physical exam-
ination, there was rebound tenderness of the right lower ab-
dominal quadrant. Laboratory examinations showed a leuko-
cytosis (total white cell count 14×109/l), an elevated C-reactive
protein level (54 mg/l), an elevated erythrocyte sedimentation
rate (29 mm/h), and no other abnormalities. A pregnancy test
was negative and urine sediment was normal. An abdominal
ultrasonography could not visualize the appendix, but showed
enlarged mesenteric lymph nodes. A CTscan showed a normal
appendix, significant thickening of the terminal ileumwall over
a length of 10 cm, enlarged mesenteric lymph nodes, and no
free intraperitoneal fluid (Fig. 1).
A terminal ileitis was suspected, with a differential diagno-
sis of M. Crohn and an infectious ileitis. Two fecal cultures
were performed and both grew Y. pseudotuberculosis on CIN
medium. The patient was treated with ciprofloxacin 500 mg
twice daily for 5 days. At follow up 2 months later, there were
no complaints, laboratory examinations were normal, and
abdominal ultrasonography showed no abnormalities.
Case 3
A previously healthy 33-year-old female presented to the
emergency department of a local hospital with progressive
right lower quadrant abdominal pain since 7 days, suspected
of appendicitis. There was no diarrhea and temperature was
37.3 °C. On physical examination, there was rebound tender-
ness of the right lower abdominal quadrant. Laboratory ex-
aminations showed normal leukocytes (total white cell count
7.9×109/l), and an elevated C-reactive protein level (31 mg/l).
Urine sediment was normal. An abdominal ultrasonography
showed thickening of the terminal ileum atypical for M.
Crohn and enlarged mesenteric lymph nodes. No CT scan
was performed.
An infectious terminal ileitis was suspected and a fecal
culture was performed. Prior to final diagnosis, treatment was
started with ciprofloxacin 500 mg twice daily for 5 days. The
fecal culture revealed growth of Y. pseudotuberculosis on CIN
medium. At follow up 1 month later, there were no complaints
Fig. 1 Computed tomography (CT) scan of case 2, showing an enlarged
mesenteric lymph node (arrow)
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and laboratory examinations were normal. No control ultra-
sound or CT scan was performed.
Results
Because of the clinical suspicion of an infectious terminal
ileitis in all three cases, fecal samples were incubated on
CIN agar at 25–28 °C, for the isolation of Yersinia species.
The cultured isolates were then identified as Y. pseudotuber-
culosis by matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) mass spectrometry (MS) (Bruker
Daltonik GmbH, Bremen, Germany) [20, 21]. Further char-
acterization of the isolated Y. pseudotuberculosis strains was
performed by serotyping and molecular techniques. Two iso-
lates belonged to serotype O1, the most frequently found type
in human infections and one isolate was not serotyped [2, 3].
Y. enterocolitica 16S rRNA polymerase chain reaction (PCR),
performed at the National Institute for Public Health and the
Environment (RIVM, Bilthoven, the Netherlands) and the
Robert Koch institute (RKI, Wernigerode, Germany), was
negative in two isolates and was not performed for one isolate.
Y. enterocolitica ail gene PCR, performed at the RKI, was
negative in all three isolates. No diagnostics were performed
for the Y. pseudotuberculosis chromosomal invA and ail gene
or the HPI, because these were not available at the RIVM and
RKI. Two isolates were positive in the Y. pseudotuberculosis
pYV PCR, performed at the RKI, and one isolate was nega-
tive. Susceptibility of the Y. pseudotuberculosis was deter-
mined with Etest (ABBiodisk, Solna, Sweden) and performed
for amoxicillin [minimum inhibitory concentration (MIC)
0.25–0.5 μg/ml], cefuroxime (MIC 0.5–0.75 μg/ml), chloram-
phenicol (MIC 1.5–3 μg/ml), ciprofloxacin (MIC 0.023–
0.047 μg/ml), and tetracycline (MIC 0.75–1.5 μg/ml).
Discussion
In 2012, three unrelated patients were diagnosed with Y.
pseudotuberculosis-associated terminal ileitis in different hos-
pitals in the Netherlands. The patients were female, between
17 and 33 years of age, and presented with progressive right
lower abdominal pain and fever. None of the patients had
underlying disease. Remarkably, radiological results were
the first indication of terminal ileitis in all patients. All patients
fully recovered after treatment with ciprofloxacin without any
complication.
The virulence of Y. pseudotuberculosis is associated with the
presence of a genetically conserved virulence plasmid, termed
pYV. It is thought that loss of pYV leads to avirulence [1, 2,
22]. pYV carries components of a type three secretion system,
which forms a needle structure on the surface of Y. pseudotu-
berculosis that interacts with target cells and enables the
injection of at least six different Yersinia outer membrane
proteins (Yops) [1, 2, 22, 23]. Yops disrupt the primary immune
response and adaptive inflammatory cascade, and, in this way,
prevent phagocytosis [2, 3, 22, 23]. Besides plasmid-encoded
genes, Y. pseudotuberculosis also have chromosomal-encoded
virulence markers, like the invA and ail genes, and some strains
harbor the HPI. The invA gene encodes for an epithelial cell
adhesion molecule, which facilitates efficient binding to intes-
tinal mucosal cells and translocation from the lumen to Peyer’s
patches. The ail gene encodes for an outer membrane protein
that mediates complement resistance; its nucleotides composi-
tion differs slightly between Y. enterocolitica and Y. pseudotu-
berculosis [18, 19, 24, 25]. The HPI encodes an iron uptake
system for the siderophore yersiniabactin and its presence
makes a strain highly virulent. HPI plays a key role in the
systemic spread of Yersinia, by which infection of the spleen
and liver can occur [3, 16].
The absence of pYV in an isolate causing terminal ileitis
(case 1) is in contradiction with the common hypothesis that
the absence of pYV leads to avirulence of the bacteria [1, 2,
22]. However, it is reported in the literature that Y. pseudotu-
berculosis can lose pYV after subculture and storage, in par-
ticular, at 37 °C [18]. Consequently, the pYV is not an ideal
DNA target for the detection of pathogenic Yersinia strains,
and it is better to combine it with the detection of a chromo-
somal virulence gene [17]. Animal infection studies showed
that pYV-negative Y. pseudotuberculosis strains are able to
establish intestinal infections and even colonize the Peyer’s
patches and mesenteric lymph nodes, showing that the pres-
ence of pYV is not required for the entry of Yersinia into host
tissues [3, 26]. For instance, Fukushima et al. reported a case
of a Japanese girl with a mesenteric lymphadenitis caused by a
pYV-negative Y. pseudotuberculosis that was positive for the
chromosomal virulence markers [26]. So, although the loss of
pYV leads to a significant decrease in the level of virulence, it
seems likely that, also, pYV-negative strains can cause human
infection [3, 26].
Although the reported incidence of human infections due to
Y. pseudotuberculosis is low, this may be due to the fact that
CIN agar is not systematically used for the culture of Yersinia
spp. in diarrheal patients. Moreover, most of the molecular
diagnostic techniques use the Y. enterocolitica ail gene as the
target, which is not present in Y. pseudotuberculosis [24, 27,
28]. This means that selective culture techniques or the perfor-
mance of a specific Y. pseudotuberculosis PCR are warranted
when Y. pseudotuberculosis is suspected, and also when diar-
rhea is not present. We also want to encourage the development
of Y. pseudotuberculosis-specific PCRs for the combined de-
tection of pYVand chromosomal-encoded genes in the light of
the pYV-negative cultured Y. pseudotuberculosis isolate.
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